Literature DB >> 19638985

The mysterious steps in carcinogenesis.

D Brash, J Cairns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638985      PMCID: PMC2720245          DOI: 10.1038/sj.bjc.6605171

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
The mutational changes needed to create a cancer cell have been itemised in great detail (Hahn and Weinberg, 2002). These mutations are commonly assumed to accumulate over the course of years as a consequence of spontaneous replication errors or, in special cases, the misrepair of DNA lesions introduced by carcinogens such as tobacco smoke or sunlight. Yet, there are numerous discrepancies between the mutagenicity of chemicals and their danger to humans (Clemmesen and Hjalgrim, 1977; Jansen ; Ames ), and the time course of carcinogenesis is deeply mysterious. Indeed, we still do not know the proximate causes of most cancers even though these are what we want to learn how to avoid. The classical method for creating cancers, in rabbits (Friedewald and Rous, 1944) in mice (Berenblum and Shubik, 1947) and perhaps in humans (Pott, 1775), by applying coal tar to the skin, involves a sequence of steps, called initiation and promotion (Friedewald and Rous, 1944), which bear no obvious relation to what is now known about the molecular biology of cancer. For example, a mouse can be ‘initiated’ by feeding it once with 1 mg of the coal tar derivative 9,10-dimethyl-1,2-benzanthracene (Boutwell, 1964). This single treatment with a mutagen apparently causes cells to undergo a permanent change so that, for the rest of the mouse's life, its skin has become susceptible to the production of papillomas and carcinomas on exposure to the non-mutagenic irritants in croton oil. Surprisingly, a similar sequence has been seen using cells in vitro, where brief exposure to X-rays or methylcholanthrene apparently produces a permanent change in every cell so that, many generations later, its descendants occasionally undergo ‘spontaneous’ transformation into cancer cells (Kennedy , 1984). Why does there have to be a long interval between a cell's exposure to a mutagen and the expression of the resulting mutations, and why do only a minority of the cell's descendants express these mutations? It would have been tempting to postulate that the various methods for producing cancer in the cells of animals are not good models of human carcinogenesis, were it not for the fact that humans and animals show the same strange relationship between dose of carcinogen and time of appearance of their cancers. For example, although the incidence of lung cancer in smokers appears to be directly proportional to the number of cigarettes smoked per day (Zaridze and Peto, 1986), it is proportional to roughly the sixth power of the duration of smoking. Similarly, when rats are continuously exposed to dietary carcinogens, their incidence of cancer rises as the first or second power of the dose rate but as a much higher power of time (Druckrey, 1967; Peto ). If the carcinogen had simply to mutate a set of N genes to create cancer, the frequency of cancer should rise as the Nth power of the dose, and time would not be a major factor. These numerous experiments suggest, therefore, that mutagenic carcinogens cause just one or two events and that these (similar to the initial event in in vitro carcinogenesis) are then followed by steps that accumulate solely with the passage of time, driven perhaps by cell division. Thus, the rabbit whose ears have been painted with coal tar tends to develop its skin cancers where, months later, samples of its skin were excised and therefore had to be replaced by extra division in the surrounding epithelium (Linell, 1947). To take two well-documented examples of carcinogenesis in humans, a chimney sweep did not get scrotal cancer until after puberty when he had grown too large to climb chimneys (Pott, 1775); and smokers keep their raised rate of lung cancer for many years after they have stopped smoking (Halpern ). To recapitulate, there are examples where the sequence changes found in cancer cells are the type known to be produced by the initiating carcinogen (Brash ; Hsu ; Hainaut and Pfeifer, 2001), but the study of cancer in humans and animals, overall, has produced a very confused picture. The techniques of modern molecular biology have documented the many defects of cancer cells, so there is by now a fairly clear understanding of the basis for the dangerous properties of cancer cells. However, the picture that emerges from the classical studies of the epidemiology of human cancers and of experimental carcinogenesis in animals is hard to reconcile with what has been learnt about mutagenesis in simple systems such as the bacteria. Initiation seems to be far too efficient to be simply mutagenesis of certain oncogenes and suppressor genes, and the subsequent time-dependent steps are even more obscure. In recent years, it has become plain that the management of biological information involves several unexpected mechanisms that limit the consequences when nucleic acids and proteins are damaged. Interactions between cells can protect against their individual defects (Rubin, 2006) and, on a larger scale, the expansion of abnormal clones can be inhibited by their normal neighbours (Chao ). Within each individual cell, there is a large set of ‘heat-shock proteins’ (HSPs) that manages the folding and operation of the products of gene expression, and one of the actions of these HSPs is to sequester or remove the abnormal proteins produced as the result of mutation or chance misfolding. After exposure to harsh environmental conditions such as a sudden rise in temperature, the pattern of synthesis of the various HSPs is altered, and the inactivation of one of the many HSP genes has been shown to result in the expression of previously hidden mutations, suggesting that one function of HSPs is to allow complex evolutionary steps to occur under conditions of stress even when the changes entail a combination of several individually disadvantageous steps (Rutherford and Lindquist, 1998). Keeping those mutations masked may contribute to tumorigenesis, because inactivation of one of the HSP genes has been found to lower the frequency of skin cancer in mice exposed to initiation by dimethylbenzanthracene and promotion by phorbol esters (Dai ). The prime mystery in carcinogenesis remains the very first step, because it is hard to imagine how the numerous genetic changes found in cancer cells could have been produced in any cell as the result of a single exposure to a DNA-damaging agent, or why months or years should have to elapse before the effect of these changes is observed. Past speculations about the process of carcinogenesis (as opposed to the characteristics of the end product) have had little popularity and negligible impact. Indeed, the early suggestions that cancer cells owe their properties to mutation (Tyzzer, 1916) and that carcinogens interact with DNA (Boyland, 1952) were, in their time, violently attacked (Miller and Miller, 1952; Rous, 1959). Now, perhaps with all these recent discoveries of additional mechanisms that protect cells from damage, it may soon be possible to produce a plausible model for what is going on during carcinogenesis. At least one new idea seems to be needed, and the main purpose of this article is to alert readers to new developments that could at last start to clarify what is going on during carcinogenesis.
  20 in total

Review 1.  SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS.

Authors:  R K BOUTWELL
Journal:  Prog Exp Tumor Res       Date:  1964

2.  Surmise and fact on the nature of cancer.

Authors:  P ROUS
Journal:  Nature       Date:  1959-05-16       Impact factor: 49.962

3.  Different types of carcinogens and their possible modes of action: a review.

Authors:  E BOYLAND
Journal:  Cancer Res       Date:  1952-02       Impact factor: 12.701

4.  In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis.

Authors:  E C MILLER; J A MILLER
Journal:  Cancer Res       Date:  1952-08       Impact factor: 12.701

5.  Hsp90 as a capacitor for morphological evolution.

Authors:  S L Rutherford; S Lindquist
Journal:  Nature       Date:  1998-11-26       Impact factor: 49.962

6.  Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation.

Authors:  A R Kennedy; J Cairns; J B Little
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

7.  Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells.

Authors:  A R Kennedy; M Fox; G Murphy; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine.

Authors:  R Peto; R Gray; P Brantom; P Grasso
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

9.  Patterns of absolute risk of lung cancer mortality in former smokers.

Authors:  M T Halpern; B W Gillespie; K E Warner
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

10.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

View more
  14 in total

Review 1.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Authors:  William H Goodson; Leroy Lowe; David O Carpenter; Michael Gilbertson; Abdul Manaf Ali; Adela Lopez de Cerain Salsamendi; Ahmed Lasfar; Amancio Carnero; Amaya Azqueta; Amedeo Amedei; Amelia K Charles; Andrew R Collins; Andrew Ward; Anna C Salzberg; Annamaria Colacci; Ann-Karin Olsen; Arthur Berg; Barry J Barclay; Binhua P Zhou; Carmen Blanco-Aparicio; Carolyn J Baglole; Chenfang Dong; Chiara Mondello; Chia-Wen Hsu; Christian C Naus; Clement Yedjou; Colleen S Curran; Dale W Laird; Daniel C Koch; Danielle J Carlin; Dean W Felsher; Debasish Roy; Dustin G Brown; Edward Ratovitski; Elizabeth P Ryan; Emanuela Corsini; Emilio Rojas; Eun-Yi Moon; Ezio Laconi; Fabio Marongiu; Fahd Al-Mulla; Ferdinando Chiaradonna; Firouz Darroudi; Francis L Martin; Frederik J Van Schooten; Gary S Goldberg; Gerard Wagemaker; Gladys N Nangami; Gloria M Calaf; Graeme Williams; Gregory T Wolf; Gudrun Koppen; Gunnar Brunborg; H Kim Lyerly; Harini Krishnan; Hasiah Ab Hamid; Hemad Yasaei; Hideko Sone; Hiroshi Kondoh; Hosni K Salem; Hsue-Yin Hsu; Hyun Ho Park; Igor Koturbash; Isabelle R Miousse; A Ivana Scovassi; James E Klaunig; Jan Vondráček; Jayadev Raju; Jesse Roman; John Pierce Wise; Jonathan R Whitfield; Jordan Woodrick; Joseph A Christopher; Josiah Ochieng; Juan Fernando Martinez-Leal; Judith Weisz; Julia Kravchenko; Jun Sun; Kalan R Prudhomme; Kannan Badri Narayanan; Karine A Cohen-Solal; Kim Moorwood; Laetitia Gonzalez; Laura Soucek; Le Jian; Leandro S D'Abronzo; Liang-Tzung Lin; Lin Li; Linda Gulliver; Lisa J McCawley; Lorenzo Memeo; Louis Vermeulen; Luc Leyns; Luoping Zhang; Mahara Valverde; Mahin Khatami; Maria Fiammetta Romano; Marion Chapellier; Marc A Williams; Mark Wade; Masoud H Manjili; Matilde E Lleonart; Menghang Xia; Michael J Gonzalez; Michalis V Karamouzis; Micheline Kirsch-Volders; Monica Vaccari; Nancy B Kuemmerle; Neetu Singh; Nichola Cruickshanks; Nicole Kleinstreuer; Nik van Larebeke; Nuzhat Ahmed; Olugbemiga Ogunkua; P K Krishnakumar; Pankaj Vadgama; Paola A Marignani; Paramita M Ghosh; Patricia Ostrosky-Wegman; Patricia A Thompson; Paul Dent; Petr Heneberg; Philippa Darbre; Po Sing Leung; Pratima Nangia-Makker; Qiang Shawn Cheng; R Brooks Robey; Rabeah Al-Temaimi; Rabindra Roy; Rafaela Andrade-Vieira; Ranjeet K Sinha; Rekha Mehta; Renza Vento; Riccardo Di Fiore; Richard Ponce-Cusi; Rita Dornetshuber-Fleiss; Rita Nahta; Robert C Castellino; Roberta Palorini; Roslida Abd Hamid; Sabine A S Langie; Sakina E Eltom; Samira A Brooks; Sandra Ryeom; Sandra S Wise; Sarah N Bay; Shelley A Harris; Silvana Papagerakis; Simona Romano; Sofia Pavanello; Staffan Eriksson; Stefano Forte; Stephanie C Casey; Sudjit Luanpitpong; Tae-Jin Lee; Takemi Otsuki; Tao Chen; Thierry Massfelder; Thomas Sanderson; Tiziana Guarnieri; Tove Hultman; Valérian Dormoy; Valerie Odero-Marah; Venkata Sabbisetti; Veronique Maguer-Satta; W Kimryn Rathmell; Wilhelm Engström; William K Decker; William H Bisson; Yon Rojanasakul; Yunus Luqmani; Zhenbang Chen; Zhiwei Hu
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory.

Authors:  Ana M Soto; Carlos Sonnenschein
Journal:  Bioessays       Date:  2011-05       Impact factor: 4.345

Review 3.  Is cancer a disease set up by cellular stress responses?

Authors:  Armando Aranda-Anzaldo; Myrna A R Dent
Journal:  Cell Stress Chaperones       Date:  2021-05-24       Impact factor: 3.667

4.  A new kink in an old theory of carcinogenesis.

Authors:  Richmond T Prehn; Liisa M Prehn
Journal:  Theor Biol Med Model       Date:  2013-02-18       Impact factor: 2.432

Review 5.  The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor's growth.

Authors:  Richmond T Prehn
Journal:  Clin Dev Immunol       Date:  2010-07-27

6.  Karyotypic evolutions of cancer species in rats during the long latent periods after injection of nitrosourea.

Authors:  Mathew Bloomfield; Amanda McCormack; Daniele Mandrioli; Christian Fiala; C Marcelo Aldaz; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2014-12-16       Impact factor: 2.009

7.  Connecting the dots between breast cancer, obesity and alcohol consumption in middle-aged women: ecological and case control studies.

Authors:  E R Miller; C Wilson; J Chapman; I Flight; A-M Nguyen; C Fletcher; Ij Ramsey
Journal:  BMC Public Health       Date:  2018-04-06       Impact factor: 3.295

8.  Speciation Theory of Carcinogenesis Explains Karyotypic Individuality and Long Latencies of Cancers.

Authors:  Ankit Hirpara; Mathew Bloomfield; Peter Duesberg
Journal:  Genes (Basel)       Date:  2018-08-09       Impact factor: 4.096

9.  The mysterious steps in carcinogenesis: addendum.

Authors:  D Brash; J Cairns
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  An Integrated Experimental Design for the Assessment of Multiple Toxicological End Points in Rat Bioassays.

Authors:  Fabiana Manservisi; Clara Babot Marquillas; Annalisa Buscaroli; James Huff; Michelina Lauriola; Daniele Mandrioli; Marco Manservigi; Simona Panzacchi; Ellen K Silbergeld; Fiorella Belpoggi
Journal:  Environ Health Perspect       Date:  2016-07-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.